Ergomed

About Ergomed

Ergomed is a specialized Contract Research Organization (CRO) operating through its PrimeVigilance division, which was established in 2008 and has achieved consistent global organic growth. The company provides comprehensive pharmacovigilance services including Medical Information, Regulatory Affairs, and Quality Assurance to pharmaceutical and biotechnology clients, covering all therapy areas and medical devices. Ergomed specializes in Oncology and Rare Disease clinical trials, with a focus on both early-phase and contracted pharmacovigilance activities. The company maintains a global presence with staff based across Europe, North America, and Asia, serving as one of the leaders in pharmacovigilance and clinical research services.